ESWL on Disintegration of Renal Stones

Status Not yet recruiting

Clinical Trial Summary

The impact of different frequencies on pattern of disintegration of renal stones

Clinical Trial Description

- Prior to the introduction of extracorporeal shockwave lithotripsy (ESWL) in 1980, the only treatment available for calculi that could not pass through the urinary tract was open surgery. Since then, ESWL has become the preferred tool in the urologist's armamentarium for the treatment of renal stones, , ESWL is minimally invasive, exposes patients to less anaesthesia, and yields equivalent stone-free rates in appropriately selected patients.

- The efficacy of ESWL lies in its ability to pulverize calculi in vivo into smaller fragments, which the body can then expulse spontaneously. Shockwaves are generated and then focused onto a point within the body. The shockwaves propagate through the body with negligible dissipation of energy (and therefore damage) owing to the minimal difference in density of the soft tissues. At the stone-fluid interface, the relatively large difference in density, coupled with the concentration of multiple shockwaves in a small area, produces a large dissipation of energy. Via various mechanisms, this energy is then able to overcome the tensile strength of the calculi, leading to fragmentation. Repetition of this process eventually leads to pulverization of the calculi into small fragments that the body can pass spontaneously and painlessly.

- It is well recognized that the popularity of extracorporeal shock wave lithotripsy (SWL), despite its non-invasive character, has decreased during recent years. This is partly explained by the technological achievements in endoscopy and urologists' enthusiasm for such procedures. Another explanation is that many urologists have been insufficiently successful with SWL. The latter effect might to some extent be a result of the performance of the lithotripter used, but in too many cases, it is evident that the principles of how shock wave lithotripsy should be carried out are poorly appliedical aspect ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03939325
Study type	Observational [Patient Registry]
Source	Assiut University
Contact	Mohamed A EL Taher
Phone	01127204629
Email	mohamed_el_taher7392@yahoo.com
Status	Not yet recruiting
Phase
Start date	May 5, 2019
Completion date	June 2020

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06070714` - Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones	N/A
Completed	`NCT04077359` - Prospective Trial for Examining Hematuria Using Computed Tomography	N/A
Enrolling by invitation	`NCT04071340` - The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones
Completed	`NCT05589649` - Erector Spinae Versus Paravertebral in Pediatric PCNL	N/A
Recruiting	`NCT05833386` - Effect of Preoperative Silodosin on Feasibility of Ureteral Access Sheath Insertion	N/A
Recruiting	`NCT05634434` - Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic Characterization
Completed	`NCT03046888` - ROBOTIC PYELOLITHIOTOMY VERSUS PERCUTANEOUS NEPHROLITHOTOMY (PCNL).	N/A
Active, not recruiting	`NCT06110247` - Evaluation of Renal Oxygenation by NIRS in Pediatric Endourologic Stone Surgery
Not yet recruiting	`NCT06131151` - Comparison Between External Oblique Intercostal Block and Erector Spinae Plane Block in PCNL	N/A
Not yet recruiting	`NCT04871984` - Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis
Withdrawn	`NCT03608098` - Long Pulse Versus Short Pulse Laser Dusting for Renal Stones	N/A
Completed	`NCT02067221` - Comparison of Surgical Outcomes Between MPCNL and RIRS	N/A
Active, not recruiting	`NCT03189264` - Percutaneous Nephrolithotomy for Treatment of Kidney Stones Greater Than 2 cm	N/A
Recruiting	`NCT06101563` - Duration Between Drainage and Ureteroscopic Lithotripsy	N/A
Recruiting	`NCT05384197` - Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients	Phase 3
Enrolling by invitation	`NCT05121168` - Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy	Phase 4
Not yet recruiting	`NCT06185387` - Changes Post Percutaneous Nephrolithotomy
Completed	`NCT05697341` - Ultra Mini Percutaneous Nephrolithotomy VS Stented Extracorporeal Shock Wave Lithotripsy for Stone Management	N/A
Completed	`NCT03349099` - Impact Ureteral Sheath Design During Ureteroscopy	N/A
Completed	`NCT03318926` - Increased Tea Consumption is Associated With a Decreased Risk of Renal Stone Disease in a Taiwanese Population	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.